TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 78,312 | 72,008 | 65,788 |
Financial expenses | 51 | 16 | 44 |
Earnings before taxes | 5,426 | 9,765 | 9,973 |
EBITDA | 10,309 | 13,683 | 13,412 |
Total assets | 67,804 | 59,201 | 47,188 |
Current assets | 53,665 | 41,233 | 38,446 |
Current liabilities | 35,849 | 31,202 | 26,374 |
Equity capital | 29,579 | 25,830 | 19,507 |
- share capital | 51 | 53 | 57 |
Employees (average) | 51 | 39 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 43.6% | 43.6% | 41.3% |
Turnover per employee | 1,536 | 1,846 | 2,437 |
Profit as a percentage of turnover | 6.9% | 13.6% | 15.2% |
Return on assets (ROA) | 8.1% | 16.5% | 21.2% |
Current ratio | 149.7% | 132.1% | 145.8% |
Return on equity (ROE) | 18.3% | 37.8% | 51.1% |
Change turnover | 8,468 | 10,765 | 20,660 |
Change turnover % | 12% | 18% | 46% |
Chg. No. of employees | 12 | 12 | 5 |
Chg. No. of employees % | 31% | 44% | 23% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.